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ABSTRACT  
 
Central obesity is a significant risk factor for metabolic syndrome in adults. Central fat distribution greatly 
alters the lipid profile and induces atherogenic dyslipidaemia even in normoglycaemic, non-hypertensive 
subjects. Hence, the aim of the present study was to identify the serum lipid parameters which are altered 
with central obesity in non-diabetic, non-hypertensive subjects in Sri Lanka. A cross-sectional study was 
conducted at the Family Practice Centre of University of Sri Jayewardenepura, after obtaining ethical 
clearance and informed written consent from 227 non-diabetics, non-hypertensive subjects who were not on 
Statins. Overnight fasting venous blood was collected and assayed for serum lipid profile such as 
triglycerides (TG), total cholesterol (TC) and high density cholesterol (HDL). Low density cholesterol (LDL) 
and TG/HDL ratio were calculated.  Waist circumference (WC) was measured based on WHO and NHANES 
standards. All data were analysed using SPSS (ver.17) software. Mean age of the subjects was 40.7 ± 13.7 
years and 59.9% were females. Obese males and females were 40.7% and 49.3% respectively. In the study 
sample, mean TG and TG/HDL ratio were significantly (p<0.05) higher in obese males. However, all mean 
serum lipid parameters such as TG, TC, LDL and TG/HDL ratio were higher in both obese males and 
females and HDL was lower in them. Hence, even in non-diabetic, non-hypertensive subjects, central obesity 
has a relationship with altered lipid profile which could lead to obesity related metabolic abnormalities. 
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1.  INTRODUCTION 
 
Obesity; excessive accumulation fat in the 
body, has reached epidemic proportions 
globally. It is mainly due to an increase in the 
energy intake than the energy expenditure 
(Mukhopadhyay, S. K. 2012). Overweight and 
obesity are known as the fifth leading risk for 
global deaths and is linked with non-
communicable diseases (NCD) (World Health 
Organization 2007).  The prevalence of NCD is 
rapidly increasing in developing countries and 
according to World Health Organization, NCD 
will account for approximately three quarters of 
deaths in these countries by the year 2020 
(Kelishadi R). 
 
It was estimated that approximately 1.6 
billion people in the world, were overweight 
and at least 400 million adults were obese in 
2005. The incidence of overweight and obesity 
were at peak in the United States (62%) and 
lowest in South East Asia (14%) (World Health 
Organization 2007). In all regions women were 
more likely to be obese than men. In Sri Lanka, 
in 2000 and 2006/7 around 24% and 31.2% of 
women were found to be overweight 
respectively. A study carried out in 2005/6 
revealed that the prevalence of overweight for 
both genders among adults was 25.2% 
(Jayatissa, R., Hossain, S.M.M., Gunawardana 
S. et al 2012). 
 
Obesity has been associated with an 
increased risk for metabolic syndrome (MS) in 
adults. MS is a constellation of metabolic and 
medical abnormalities, clustered in individuals 
with upper body fat distribution who often 
show insulin resistance. Among these 
abnormalities are hyperinsulinaemia with 
diabetes and raised fasting plasma glucose, 
abdominal obesity, and dyslipidaemic profile 
characterized by a high plasma triglyceride 
(TG) concentration and low high density 
lipoprotein cholesterol (HDL) level (Crepaldi, 
G., Maggi, S. 2006). Central distribution of 
body fat, particularly intra-abdominal fat is 
more a risk factor for obesity related ill health 
than sub-cutaneous distribution (Mishra, N., 
Sharma, M. K., Chandrasekar, M. 2012). 
 
Obesity can be assessed using several 
anthropometric measurements and indices. 
Waist Circumference (WC) with ethnic specific 
values is considered as the key component of 
the MS definition and it can be used to assess 
the metabolic risk associated with intra-
abdominal fat (Crepaldi, G., Maggi, S. 2006). 
Within the last 20 years, rapidly rising rates of 
obesity have led to major increases in the 
prevalence of type 2 diabetes (T2D) and 
cardiovascular diseases. Obese people are more 
likely to have abnormal lipid profile; increasing 
the risk of atherosclerosis. Increased 
prevalence, earlier onset, and augmented 
complications of T2D and cardiovascular 
diseases are often seen with higher WC in 
South Asians than in white Caucasians 
(Chakrewarthy, S., Gunasekera, D., 
Pathmeswaren A. et al 2006). 
 
Abnormal lipid profile has long been 
suspected to contribute to atherogenic 
dyslipidaemia, which describes the combination 
of raised TG and low concentrations of HDL 
cholesterol together with elevated 
apolipoprotein B. Low HDL cholesterol and 
high TG levels are considered as major 
components of the definition for the MS given 
by International Diabetic Federation (IDF) 
(Vishwanath, P., Prashant, A., Acharya A. 
2012). These are independently atherogenic and 
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they are commonly observed in people with 
both central obesity and T2D. Overweight and 
obese people had significantly high TG, total 
cholesterol (TC) and low density lipoprotein 
(LDL) cholesterol (Thakur, J. S., Bisht, S. 
2010). Indian obese people were found to have 
high TG, TC and LDL and low HDL than non-
obese (Puavilai, W., Laoragpongse, D. 2004). 
Hence, obesity alone is a major independent 
risk factor for altered lipid profile giving rise to 
atherogenic dyslipidaemia.  
 
Obesity induced diseases are diagnosed 
only after symptoms appear and many people 
are unaware that it alone could gives rise to 
atherogenic dyslipidaemia which is a major 
abnormality of metabolic syndrome. Therefore 
early detection would be a pre-alarming sign 
before the onset of developing obesity induced 
diseases and it would be of significant value to 
the individuals to overcome the risk of getting 
diseases. Even though obesity prevalence is 
high in Sri Lanka, people are unaware that 
central obesity alone could give rise to 
atherogenic lipid profile. Hence, the aim of this 
study was to identify the altered serum 
parameters with central obesity in non-diabetic, 
non-hypertensive subjects in Sri Lanka. 
 
2.  MATERIALS AND METHODS 
 
a. Study population and sampling 
 
This study was conducted as a cross-sectional 
study, at the Family Practice Centre, University 
of Sri Jayewardenepura (USJP) involving 227 
non-diabetic (FPG<5.9 mmol/L), non-
hypertensive subjects, between 20-70 years of 
age. The study was approved by the Ethics 
Review Committee of USJP and informed 
written consent was obtained from all the 
participants prior to the study. 
 
b. Measurements 
 
After an overnight fasting period (12 hours), 
venous blood samples were collected from each 
subject. The parameters of the lipid profile (TC, 
TG and HDL) were measured based on the 
Beer Lambert law using Stanbio
®
 kits involving 
an enzymatic method. LDL was calculated 
using the Friedwald equation as given below. 
 
LDL-C = TC – HDL - [TG/5]     [11] 
 
(The use of Triglyceride/5 indicates that all 
of the plasma TG is carried on VLDL-C and 
TG/ cholesterol ratio of VLDL-C is constant at 
about 5:1 [11]). 
 
WC of each subject was measured using a 
non-stretchable measuring tape. Participants 
were asked to stand with arms at sides, feet 
positioned close together, in a relaxed posture 
while breathing naturally. The measurement 
was made at the approximate midpoint between 
the lower margin of the last palpable rib and the 
crest of the ileum (top of the hip bone), placing 
the non-stretchable tape around the trunk in a 
horizontal plane. The tape was parallel to the 
floor and it was without compressing the skin. 
The measurement was made at the end of a 
normal expiration to the nearest 0.1 cm (Lui, A. 
2008). 
 
c. Definitions 
  
The results were arranged based on the 
definition of MS according to the IDF criteria 
given below:  
1. Central obesity ; for males >90 cm and 
for females >80 cm 
2. Raised triglycerides >150 mg/dL  
3. Low HDL – cholesterol <40 mg/dL 
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 Those presented with central obesity 
together with above two criteria were 
considered as having MS.  
 
 All the subjects were categorised into 
subgroups depending on the classification given 
by the Adults Treatment Panel III (Mekki, N., 
Christofilis, M. A., Charbonnier, M. et al 
1999), Aziz, J., Siddiqui, A. N., Siddiqui, I. A., 
Omai, A. 2003).
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Table 1. Classification of  serum lipid parameters 
 
Lipid parameter Concentration Classification 
Serum triglycerides < 150 mg/dL 
150 – 199 mg/dL 
≥200  mg/dL 
Normal 
Borderline high 
High  
HDL cholesterol < 40 mg/dL 
≥ 60 mg/dL 
Low 
High 
LDL cholesterol < 100 mg/dL 
100 – 129 mg/dL 
≥130  mg/dL 
Normal  
Near optimal 
high 
TG/HDL ratio  ≤ 2 
>2.1 
Low 
High 
   
 
d. Statistical analysis 
 
All data were double-entered and cross checked for consistency. Data were analysed using 
Statistical Package for Social Science (SPSS) software (Ver. 17). All the analysis was carried out 
for males and females separately. Descriptive statistical results were presented as means ± standard 
deviations. Independent sample t-Test was used to assess the significant differences among obese 
and non-obese groups. In all statistical analyses a p-value <0.05 was considered as significant. 
  
3.   RESULTS  
 
Among 227 subjects, 91 were males and 136 were females. Mean ± SD of the sample 
characteristics are mentioned in table 2.  
 
According to the classification of WC based on the metabolic risk level (Lakka, H. M., Lakka, T. 
M., Tuomilehto, et al J 2002), among the males 40.7% were obese and 49.3% of the females were 
obese. Obese males’ TG was at a borderline high level whereas LDL was slightly above the normal 
(Mekki, N., Christofilis, M. A., Charbonnier, M. et al 1999) TG/HDL ratio in both males and 
females were at the risk level Aziz, J., Siddiqui, A. N., Siddiqui, I. A., Omai, A. 2003). 
 
Table 2. Mean ± SD values of the study sample 
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116.8 
167.6* 
112.2 
120.4 
 
 
parameters of  males and females based on waist circumference 
* Differences are significant at p<0.05. 
 
 
 
 
 
 
Table 3 shows the mean values of lipid profile 
variables in obese and non-obese males and 
females according to the WC cut off values. 
When different lipid parameters were compared 
with WC, cut off values for obese and non-
obese individuals, obese males and females had 
high TC, TG, LDL and TG/HDL ratio and low 
HDL than non-obese subjects, but the 
difference was significant only in males, for TG 
and TG/HDL ratio (p<0.05). 
 
Our results indicate both obese males 
and females have higher plasma levels of lipid 
parameters. Many other studies have also 
shown that triglycerides accumulation in 
plasma is higher in obese subjects as well as 
overproduction of LDL and reduced clearance 
of the lipid particles [16]. Similarly, a study 
carried out in Pakistan found that mean TG, TC 
and LDL levels had a higher risk of getting 
elevated in obese subjects compared to non-
obese subjects even in the absence of 
cardiometabolic diseases [17].  
 
  Male obese subjects are more 
vulnerable to have altered lipid parameters with 
metabolic abnormalities. According to 
literature, higher WC has a twofold risk of 
metabolic impairments, especially coronary 
heart diseases in men [18]. A study carried out 
in Indian males has found that obese subjects 
with higher WC have an association with 
altered lipid profiles in terms of TG, TC and 
LDL (Puavilai, W., Laoragpongse, D. 2004). Our 
study results support these findings. Thus, 
central obesity measured by WC has an 
association with elevated TG levels and 
TG/HDL ratio and is significant in males. 
 
4. CONCLUSIONS AND FUTURE WORK 
 
The present study shows that central obesity is 
an independent risk factor in causing 
abnormalities in plasma lipid profile, mainly 
TG and has a significant effect in males. It 
changes the TG/HDL ratio which alters HDL 
levels as well. Therefore, even in the absence of 
diabetes and hypertension, obese subjects have 
a high tendency to develop metabolic 
abnormalities. Hence, simple measurement 
such as WC could be strongly recommended to 
be used routinely at medical checkups to detect 
the risk of developing obesity related metabolic 
abnormalities and to recommend healthy life 
style modifications with a proper diet and 
necessary physical activities. Furthermore, 
researches are currently being conducted in 
larger populations on the same topic to 
ascertain the validity of the present study as 
applicable to the country.  
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